Clinical Trials Browser

Unknown × Rituximab × Dermatologic × Clear all

NCT02142335 2014-05-20

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Phase 2 Unknown

Melanoma